Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity

Neurology

Volumn 67, Issue 8, 2006, Pages 1432-1436

  Bensmail, D ^a   Salva, M A Quera ^a   Roche, N ^a   Benyahia, S ^a   Bohic, M ^a   Denys, P ^a   Bussel, B ^c   Lofaso, F ^a,b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CLONAZEPAM; DANTROLENE; DIAZEPAM; TETRAZEPAM;

ADULT; ARTERIAL GAS; ARTICLE; CARBON DIOXIDE BREATHING; CEREBRAL PALSY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; FRIEDREICH ATAXIA; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LEG MOVEMENT; LUNG FUNCTION TEST; MALE; MULTIPLE SCLEROSIS; MUSCLE SPASM; OXYGEN CONSUMPTION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PUMP; RESPIRATORY FUNCTION; SLEEP; SPASTICITY; SPINAL CORD INJURY;

ADULT; BACLOFEN; CIRCADIAN RHYTHM; FEMALE; HUMANS; INJECTIONS, SPINAL; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; RESPIRATION; RESPIRATORY FUNCTION TESTS; REST; SEVERITY OF ILLNESS INDEX; SLEEP; SPINAL CORD INJURIES;

EID: 33750298362     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000239827.38036.23     Document Type: Article

References (45)

1. Biering-Sorensen F, Biering-Sorensen M. Sleep disturbances in the spinal cord injured: an epidemiological questionnaire investigation, including a normal population. Spinal Cord 2001;39:505-513.
2. Ferini-Strambi L, Filippi M, Martinelli V, et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci 1994;125:194-197.
3. Tachibana N, Howard RS, Hirsch NP, Miller DH, Moseley IF, Fish D. Sleep problems in multiple sclerosis. Eur Neurol 1994;34:320-323.
4. Penn RD, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984;1:1078.
5. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991;265:1418-1422.
6. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996;77:35-39.
7. Francisco GE, Boake C. Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study. Arch Phys Med Rehabil 2003;84:1194-1199.
8. Lazorthes Y, Sallerin-Caute B, Verdie JC, Bastide R, Carillo JP. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 1990;72:393-402.
9. Middel B, Kuipers-Upmeijer H, Bouma J, et al. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 1997;63:204-209.
10. Ochs G, Struppler A, Meyerson BA, et al. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J Neurol Neurosurg Psychiatry 1989;52:933-939.
11. Parke B, Penn RD, Savoy SM, Corcos D. Functional outcome after delivery of intrathecal baclofen. Arch Phys Med Rehabil 1989;70:30-32.
12. Kravitz HM, Corcos DM, Hansen G, Penn RD, Cartwright RD, Gianino J. Intrathecal baclofen. Effects on nocturnal leg muscle spasticity. Am J Phys Med Rehabil 1992;71:48-52.
13. McCarty SF, Gaebler-Spira D, Harvey RL. Improvement of sleep apnea in a patient with cerebral palsy. Am J Phys Med Rehabil 2001;80:540-542.
14. Baydur A, Adkins RH, Milic-Emili J. Lung mechanics in individuals with spinal cord injury: effects of injury level and posture. J Appl Physiol 2001;90:405-411.
15. Linn WS, Adkins RH, Gong H Jr, Waters RL. Pulmonary function in chronic spinal cord injury: a cross-sectional survey of 222 southern California adult outpatients. Arch Phys Med Rehabil 2000;81:757-763.
16. Ghose K, Holmes KM, Matthewson K. Complications of baclofen over-dosage. Postgrad Med J 1980;56:865-867.
17. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-542.
18. Penn RD, Savoy SM, Corcos D, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989;320:1517-1521.
19. Sharpley AL, Solomon RA, Cowen PJ. Evaluation of first night effect using ambulatory monitoring and automatic sleep stage analysis. Sleep 1988;11:273-276.
20. Rechtschaffen A, Kales A. eds. A manual of standardized terminology, techniques and scoring system for sleep stage of human subjects. Los Angeles, 1968.
21. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-184.
22. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-689.
23. Recording and scoring leg movements. The Atlas Task Force. Sleep 1993;16:748-759.
24. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-65.
25. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J (Suppl) 1993;16:5-40.
26. Heritier F, Rahm F, Pasche P, Fitting JW. Sniff nasal inspiratory pressure. A noninvasive assessment of inspiratory muscle strength. Am J Respir Crit Care Med 1994;150:1678-1683.
27. Prigent H, Lejaille M, Falaize L, et al. Assessing inspiratory muscle strength by sniff nasal inspiratory pressure. Neurocrit Care 2004;1:475-478.
28. Hart N, Polkey MI, Sharshar T, et al. Limitations of sniff nasal pressure in patients with severe neuromuscular weakness. J Neurol Neurosurg Psychiatry 2003;74:1685-1687.
29. Stefanutti D, Benoist MR, Scheinmann P, Chaussain M, Fitting JW. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med 2000;162:1507-1511.
30. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969;99:696-702.
31. Black LF, Hyatt RE. Maximal static respiratory pressures in generalized neuromuscular disease. Am Rev Respir Dis 1971;103:641-650.
32. Adler JJ. A simplified method for evaluating the ventilatory response to carbon dioxide. Am Rev Respir Dis 1973;108:1449-1450.
33. Melchior JC, Raguin G, Boulier A, et al. Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections. Am J Clin Nutr 1993;57:614-619.
34. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945;1:80-83.
35. de Mello MT, Lauro FA, Silva AC, Tufik S. Incidence of periodic leg movements and of the restless legs syndrome during sleep following acute physical activity in spinal cord injury subjects. Spinal Cord 1996;34:294-296.
36. Esteves AM, de Mello MT, Lancellotti CL, Natal CL, Tufik S. Occurrence of limb movement during sleep in rats with spinal cord injury. Brain Res 2004;1017:32-38.
37. Yokota T, Hirose K, Tanabe H, Tsukagoshi H. Sleep-related periodic leg movements (nocturnal myoclonus) due to spinal cord lesion. J Neurol Sci 1991;104:13-18.
38. Finnimore AJ, Roebuck M, Sajkov D, McEvoy RD. The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J 1995;8:230-234.
39. Guilleminault C, Flagg W. Effect of baclofen on sleep-related periodic leg movements. Ann Neurol 1984;15:234-239.
40. Ulloor J, Mavanji V, Saha S, Siwek DF, Datta S. Spontaneous REM sleep is modulated by the activation of the pedunculopontine tegmental GABAB receptors in the freely moving rat. J Neurophysiol 2004;91:1822-1831.
41. Manfridi A, Brambilla D, Mancia M. Sleep is differently modulated by basal forebrain GABA(A) and GABA(B) receptors. Am J Physiol Regul Integr Comp Physiol 2001;281:R170-R175.
42. Lalley PM. Effects of baclofen and gamma-aminobutyric acid on different types of medullary respiratory neurons. Brain Res 1986;376:392-395.
43. Persson B. GABAergic mechanisms in blood pressure control. A pharmacological analysis in the rat. Acta Physiol Scand (Suppl) 1980;491:1-54.
44. Persson B, Henning M. Central cardiovascular and biochemical effects of baclofen in the conscious rat. J Pharm Pharmacol 1980;32:417-422.
45. Kroin JS, Ali A, York M, Penn RD. The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery 1993;33:226-230.